8-K current report · filed Oct 5, 2026

DocGo Inc. (DCGO) 8-K Current Report: October 5, 2026

Item 1.01Item 1.02Item 8.01Item 2.03Item 3.02DCGO overview

Short answer

DocGo Inc. (DCGO) filed an 8-K current report with the SEC on October 5, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 8.01 (Other Events), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities). Refinanced $52M existing debt and added $12.5M Term Loan B immediately.

DocGo Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Refinanced $52M existing debt and added $12.5M Term Loan B immediately
  • Additional $12.5M Term Loan C tied to merger completion, plus $25M delayed-draw capacity through December 31, 2027
  • High-cost debt: Term SOFR with 3.50% floor plus 7.50% margin, maturing December 6, 2029
  • First-priority liens on substantially all personal property, increasing lender recovery priority
  • Lender received fully vested warrant for 4M shares at $0.5039, exercisable for 10 years, creating potential dilution
  • Stock repurchases capped at $40M and require administrative-agent consent plus covenant compliance

Item 1.02 · Termination of a Material Definitive Agreement

  • Existing revolving credit facility terminated October 1, 2026 before new Credit Agreement entry
  • All undrawn commitments canceled, eliminating access to the prior revolver
  • Related guarantees and liens discharged, releasing collateral and associated security obligations

Item 3.02 · Unregistered Sales of Equity Securities

  • Warrant issued to the administrative agent as consideration for entering the Credit Agreement
  • Potential warrant shares represent future equity dilution, with terms incorporated from Item 1.01
  • Private-placement exemption under Securities Act Section 4(a)(2), without underwriters or commissions
  • Warrant and shares restricted from U.S. resale absent registration or an exemption
  • Common shares outstanding totaled 98,992,347 as of October 1, 2026

Item 8.01 · Other Events

  • Ambulnz begins managing Hicuity’s non-clinical operations effective October 1, 2026
  • Consulting Services Agreement closing conditions satisfied, activating the arrangement
  • Operational handoff may affect Hicuity’s cost structure and execution, with financial terms not disclosed in this item

Other items in this filing:

  • Item 2.03: Creation of a Direct Financial Obligation

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other DocGo Inc. 8-K filings

Get the next DCGO 8-K as it lands

Follow DCGO for push alerts, or ask the research agent what this filing means.